The role of NO in ischemia/reperfusion injury in isolated rat heart

General Physiology and Biophysics

Volumn 24, Issue 4, 2005, Pages 411-426

  Andelová, Eva ^a   Bartekova M ^a   Pancza, D ^a   Styk, J ^a   Ravingerova T ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Heart; Ischemia; Preconditioning; Rat; Reperfusion

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADAPTATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART ARRHYTHMIA; HEART CONTRACTION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INCIDENCE; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; PROVOCATION TEST; RAT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY CIRCULATION; MYOCARDIAL CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; REPERFUSION INJURY; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA;

EID: 33144462725     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Ambrosio G., Tritto I., Chiariello M. (1994): Oxygen free radicals and preconditioning. In: International Society for Heart Research. European Section Meeting, Copenhagen, Denmark (Eds. S. Haunso and K. Kjeldsen), pp. 87-91, Monduzzi Editore, Bologna
2. Balligand J. L., Kelly R. A., Marsden P. A., Smith T. W., Michel T. (1993): Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U.S.A. 90, 347-351
3. Balligand J. L., Kobzik L., Han X. (1995): Nitric oxide dependent para-sympathetic signaling is due to activation of constitutive endothelial nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270, 14582-14586
4. Banerjee S., Tang X. L., Qiu Y., Takano H., Manchikalapudi S., Dawn B., Shirk O., Bolli R. (1999): Nitroglycerine induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am. J. Physiol. 277, H2488-2494
5. Baxter G. F., Yellen D. M. (1997): Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit. J. Cardiovasc. Pharmacol. 29, 631-638
6. 2- and NO generation in the post-ischemic guinea-pig heart. Cardiovasc. Res. 63, 118-129
7. Bolli R. (2001): Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33, 1897-1918
8. Bolli R., Marban E. (1999): Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79, 609-634
9. Bolli R., Bhatti Z. A., Tang X. L., Qiu Y., Zhang Q., Guo Y., Jadoon A. K. (1997a): Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res. 81, 42-52
10. Bolli R., Manchikalapudi S., Tang X. L., Takano H., Qiu Y., Guo Y. (1997b): The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: Evidence that nitric oxide acts both as trigger and as a mediator of the late phase of ischemic preconditioning. Circ. Res. 81, 1094-1107
11. Brown G. C., Borutaite V. (2002): Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33, 1440-1450
12. Deutsch E., Berger M., Kussmaul W. G., Hirschfield J. W., Hermann H. C., Laskey W.K. (1990): Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical metabolic and haemodynamic features. Circulation 82, 2044-2051
13. Dusting G. J. (1996): Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. In: Myocardial Ischemia: Mechanisms, Reperfusion, Protection (Ed. M. Karmazyn), pp. 33-55, Birkhauser Verlag, Basel
14. Feng Q., Lu X., Jones D. L., Shen J., Arnold J. M. (2001): Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104, 700-704
15. Ferdinandy P. (2004): Nitric oxide and peroxynitrite in cardioprotection: The effect of hyperlipidaemia. Cardiovasc. J. S. Afr. 15 (Suppl 1), 4
16. Ferdinandy P., Schulz R. (2003): Nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138, 532-543
17. Ghosh S., Standen N. B., Galinianes M. (2001): Failure to precondition pathological human myocardium. J. Am. Cell. Cardiol. 37, 711-718
18. Hill M., Takano H., Tang X. L., Kodani E., Shirk G., Bolli R. (2001): Nitroglycerin induce late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104, 694-699
19. + (ATP) channels and cGMP in the preconditioning response of the rabbit. J. Surg. Res. 92, 56-63
20. Ignarro L. J., Harbison R. G., Wood K. S., Kadowitz P. J. (1986): Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. Proc. Natl. Acad. Sci. U.S.A. 237, 893-900
21. Ignarro L. J., Napoli C., Loscalzo J. (2002): Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circulation 90, 21-28
22. Juhasz B., Der P., Turoczi T., Backay I., Varga E., Tosaki A. (2004): Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma? Antioxid. Redox Signal. 6, 325-333
23. Kawaguchi H., Shin W. S., Wang Y., Inukai M., Kato M., Matsuo-Okai Y., Sakamoto A., Uehara Y., Kaneda Y., Toyo-oka T. (1997): In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes. Circulation 95, 2441-2447
24. Kitakaze M., Hori M., Takashima S., Sato H., Inoue M., Kamada T. (1993): Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. (Erratum in: Vol. 87, pp. 1775, 2070) Circulation 87, 208-215
25. Kitakaze M., Minamino T., Node K., Takashima S., Funaya H., Kuzuya T., Hori M. (1999): Adenosine and cardioprotection in the diseased heart. Jpn. Circ. J. 63, 231-243
26. Ku D. D., Liu S., Dai J. (1995): Coronary vascular and antiplatelet effects of peroxynitrite in human tissues. Endothelium 3, 309-319
27. Lecour S., Maupoil V., Zeller M., Laubriet A., Briot T., Rochette L. (2001): Levels of nitric oxide in the heart after experimental myocardial ischemia. J. Cardiovasc. Pharmacol. 37, 55-63
28. Lefer D. J., Scalia R., Campbell B., Nossuli T. O., Hayward R., Salamon M. (1997): Peroxynitrite inhibits loukocyte endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest. 99, 684-691
29. Lieberthal W., McGarry A. E., Sheils J., Valeri C. R. (1991): Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am. J. Physiol. 261, F868-872
30. Liu C. S., Thornton J., Van Winkle D. M., Stanley A. W. H., Olsson R. A., Downey J. M. (1991): Protection against infection afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84, 350-356
31. Liu P., Hock C. E., Nagele R., Wong P. Y. (1997): Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am. J. Physiol. 272, H2327-2336
32. Lohmann S. M., Fischmeister R., Walter U. (1991): Signal transduction by cGMP in heart. Basic Res. Cardiol. 86, 503-514
33. Matheis G., Sherman M. P., Buckberg G. D., Haybron D. M., Young H. H., Ignarro L. J. (1992): Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262, H616-620
34. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 88, 1197-1201
35. Mizumura T., Nithipatikom K., Gross G. J. (1995): Effect of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc. Res. 29, 482-489
36. Murry C. E., Jennings R. B., Reimer K. A. (1986): Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
37. Nakano A, Cohen M. V., Downey J. M. (2000a): Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol. Ther. 86, 263-275
38. Nakano A., Liu C. S., Heusch G., Downey J. M., Cohen M. V. (2000b): Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J. Mol. Cell. Cardiol. 32, 1159-1167
39. Nassem S. A., Kontos M. C., Rao P. S., Jesse R. I., Hess M. L., Kukreja R. C. (1995): Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J. Mol. Cell. Cardiol. 27, 419-426
40. Pagliaro P., Chiribiri A., Mancardi D., Rastaldo R., Gattullo D., Losano G. (2003): Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning. Ital. Heart J. 4, 383-394
41. Parratt J. R., Vegh A., Papp J. C. (1995): Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning: a brief review of the evidence. Can. J. Physiol. Pharmacol. 73, 837-842
42. Patel V. C., Yellen D. M., Singh K. J., Neild G. H., Woolfson R. G. (1993): Inhibition of nitric oxide limits infarct size in the situ rabbit heart. Biochem. Biophys. Res. Commun. 194, 234-238
43. Pernow J., Uriuda Y., Wang Q. D., Nordlander R., Rydeen L. (1994): The protective effect of L-arginine on myocardial injury and endothelial function following ischemia and reperfusion in the pig. Eur. Heart J. 15, 1712-1719
44. Ravingerová T., Pyne N. J., Parratt J. R. (1995): Ischemic preconditioning in the rat heart: the role of G-proteins and adrenergic stimulation. Mol. Cell. Biochem. 147, 123-128
45. Saito T., Hu F., Tayara L., Fahas L., Shennib H., Giaid A. (2002): Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am. J. Physiol. 283, H339-345
46. Sato H., Zhao Z. Q., McGee D. S., Williams M. W., Hammon J. W. Jr., Vinten-Johansen J. (1995): Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J. Thorac. Cardiovasc. Surg. 110, 302-314
47. Sedat A., Demiryürek A. T., Cakici I., Kanzik I. (1999): The beneficial effects of peroxynitrite on ischemia-reperfusion arrhythmias in rat isolated hearts. Eur. J. Pharmacol. 384, 157-162
48. + channels openers in guinea-pig ventricular ceus. Br. J. Pharmacol. 120, 1568-1574
49. Solomon S. D., Anavekar N. S., Greaves S., Rouleau J. L., Hennekens C., Pfeffer M., A. HEART Investigators (2004): Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. J. Am. Coll. Cardiol. 43, 1511-1514
50. Tsao P. S., Lefor A. M. (1990): Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am. J. Physiol. 259, H1660-1666
51. Vegh A., Szekeres L., Parratt J. R. (1992): Preconditioning of the ischemic myocardium: involvement of the L-arginine nitric oxide pathway. Br. J. Pharmacol. 107, 648-652
52. Walker M. J. A., Curtis M. J., Hearse D. J., Campbell R. W. F., Janse M. J., Yellon D. M., Cobbe S. M., Coker S. J., Harness J. B., Harron D. W. G., Higgins A. J., Julian D. J., Lab M. J., Manning A. S., Northover B. J., Parratt J. R., Riemersma R. A., Riva E., Russel D. C., Sheridan D. J., Winslow E., Woodward B. (1988): The Lambeth conventions: guidelines for the study of arrhythmias in ischemia, infarction and repefusion. Cardiovasc. Res. 22, 447-455
53. Wang D., Yang X. P., Liu Y. H., Carretero O. A., LaPointe M. C. (1999): Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am. J. Hypertens. 12, 174-182
54. Wang P., Zweier J. L. (1996): Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. J. Biol. Chem. 271, 223-230
55. Weiland U., Haendeler J., Ihling C., Albus U., Sholtz W., Reutten H. (2000): Inhibitions of endogenous nitric oxide synthase potentiates ischemia-reperfused-induced myocardial apoptosis via a ca-spase-3 dependent pathway. Cardiovasc. Res. 45, 671-678
56. Williams M. W., Taft C. S., Ramnauth S., Zhao Z. Q., Vinten-Johansen J. (1995): Endogenous nitric oxide protects against ischemia-reperfusion injury in the rabbit. Cardiovasc. Res. 30, 79-86
57. Xuan Y. T., Tang X. L., Qui Y., Banerjee S., Takano H., Han H., Bolli R. (2000): Biphasic response of cardiac NO synthase to ischemic preconditioning in conscious rabbits. Am. J. Physiol. 279, H2360-2371
58. Yasmin W., Strynadka K. D., Schulz R. (1997): Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res. 33, 422-432
59. Yellon D. M., Alkhulaifi A. M., Pugsley W. B. (1993): Preconditioning the human myocardium. Lancet 342, 276-277
60. Zhang Y., Bissing J. W., Xu L., Ryan A. J., Martin S. M., Miller F. J. Jr., Kregel K. C., Buettner G. R., Kerber R. E. (2001): Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. J. Am. Coll. Cardiol. 38, 546-554